| 臺大學術典藏 |
2021-03-19T06:57:18Z |
Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients
|
Liu K.-L.;Lee B.-C.;Ye J.-D.;Chang Y.-H.;Chang C.-C.;Huang K.-H.;Lee Y.-J.;Yeun-Chung Chang; Liu K.-L.; Lee B.-C.; Ye J.-D.; Chang Y.-H.; Chang C.-C.; Huang K.-H.; Lee Y.-J.; YEUN-CHUNG CHANG |
| 臺大學術典藏 |
2021-03-18T08:54:42Z |
131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results
|
Yen R.-F.; Wu V.-C.; Liu K.-L.; Cheng M.-F.; YEN-WEN WU; Chueh S.-C.; Lin W.-C.; Wu K.-D.; Tzen K.-Y.; Lu C.-C.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-03-18T05:59:12Z |
131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results
|
Yen R.-F.; Wu V.-C.; Liu K.-L.; Cheng M.-F.; Wu Y.-W.; Chueh S.-C.; Lin W.-C.; Wu K.-D.; KAI-YUAN TZEN; Lu C.-C.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-03-18T05:59:04Z |
Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy
|
Lu C.-C.; Wu V.-C.; Wu K.-D.; Liu K.-L.; Lin W.-C.; Cheng M.-F.; KAI-YUAN TZEN; Yen R.-F.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chueh S.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:14Z |
Primary primitive neuroectodermal tumor of the urinary tract
|
Huang K.-H.;Chia-Tung Shun;Huang S.-Y.;Yu H.-J.;Chueh S.-C.;Chen J.; Huang K.-H.; CHIA-TUNG SHUN; Huang S.-Y.; Yu H.-J.; Chueh S.-C.; Chen J. |
| 臺大學術典藏 |
2021-03-18T02:03:14Z |
Primary amyloidosis of the urinary bladder
|
Huang C.-Y.;Chia-Tung Shun;Huang K.-H.;Chen J.;Pu Y.-S.; Huang C.-Y.; CHIA-TUNG SHUN; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:09Z |
Malignant epithelioid angiomyolipoma of the kidney.
|
Huang K.H.; Huang C.Y.; Chung S.D.; Pu Y.S.; CHIA-TUNG SHUN; Chen J. |
| 臺大學術典藏 |
2021-03-18T02:03:05Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Chia-Tung Shun;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Pu Y.-S.; Chen C.-H.; CHIA-TUNG SHUN; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:03:02Z |
Characteristics of Female Non-Muscle-Invasive Bladder Cancer in Taiwan: Association with Upper Tract Urothelial Carcinoma and End-Stage Renal Disease
|
Chen C.-H.; CHIA-TUNG SHUN; Huang K.-H.; Huang C.-Y.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:52Z |
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
|
Chen C.-H.; Yang H.-J.; CHIA-TUNG SHUN; Huang C.-Y.; Huang K.-H.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:49Z |
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|
Chen C.-H.;Dickman K.G.;Huang C.-Y.;Moriya M.;Chia-Tung Shun;Tai H.-C.;Huang K.-H.;Wang S.-M.;Lee Y.-J.;Grollman A.P.;Pu Y.-S.; Chen C.-H.; Dickman K.G.; Huang C.-Y.; Moriya M.; CHIA-TUNG SHUN; Tai H.-C.; Huang K.-H.; Wang S.-M.; Lee Y.-J.; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:39Z |
Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
|
Chen C.-H.; Dickman K.G.; Huang C.-Y.; CHIA-TUNG SHUN; Tai H.-C.; Huang K.-H.; Wang S.-M.; Lee Y.-J.; Grollman A.P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:24Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-18T02:02:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-10T08:55:42Z |
Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-κB-activated cyclooxygenase-2/prostaglandin e2 up-regulation
|
Lan K.-C.;Chiu C.-Y.;Kao C.-W.;Huang K.-H.;Wang C.-C.;Huang K.-T.;Keh-Sung Tsai;Sheu M.-L.;Liu S.H.; Lan K.-C.; Chiu C.-Y.; Kao C.-W.; Huang K.-H.; Wang C.-C.; Huang K.-T.; KEH-SUNG TSAI; Sheu M.-L.; Liu S.H. |
| 臺大學術典藏 |
2021-03-10T08:55:41Z |
Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice
|
Huang C.-F.; Yang C.-Y.; Chan D.-C.; Wang C.-C.; Huang K.-H.; Wu C.-C.; KEH-SUNG TSAI; Yang R.-S.; Liu S.-H. |
| 臺大學術典藏 |
2021-03-04T07:51:42Z |
Nanoparticulated honokiol mitigates cisplatin-induced chronic kidney injury by maintaining mitochondria antioxidant capacity and reducing caspase 3-associated cellular apoptosis
|
Liu, H.-T.;Wang, T.-E.;Hsu, Y.-T.;Chou, C.-C.;Huang, K.-H.;Hsu, C.-C.;Liang, H.-J.;Chang, H.-W.;Lee, T.-H.;Tsai, P.-S.; Liu, H.-T.; Wang, T.-E.; Hsu, Y.-T.; Chou, C.-C.; Huang, K.-H.; Hsu, C.-C.; Liang, H.-J.; Chang, H.-W.; Lee, T.-H.; Tsai, P.-S.; HUI-WEN CHANG; PEI-SHIUE TSAI |
| 臺大學術典藏 |
2021-03-04T07:51:14Z |
Development of nanosome-encapsulated honokiol for intravenous therapy against experimental autoimmune encephalomyelitis
|
Hsiao, Y.-P.;Chen, H.-T.;Liang, Y.-C.;Wang, T.-E.;Huang, K.-H.;Hsu, C.-C.;Liang, H.-J.;Huang, C.-H.;Jan, T.-R.; Hsiao, Y.-P.; Chen, H.-T.; Liang, Y.-C.; Wang, T.-E.; Huang, K.-H.; Hsu, C.-C.; Liang, H.-J.; Huang, C.-H.; Jan, T.-R.; TONG-RONG JAN |
| 臺大學術典藏 |
2021-03-04T02:36:03Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Yu-Chieh Tsai;Yu H.-J.;Pu Y.-S.; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; YU-CHIEH TSAI; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; YU-CHIEH TSAI; Pu Y.-S.; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; YU-CHIEH TSAI; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; YU-CHIEH TSAI; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
